thymidine has been researched along with paricalcitol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akkemik, E; Budak, H; Ciftci, M | 1 |
| Burnstein, KL; Chen, TC; Holick, MF; Lokeshwar, BL; Schwartz, GG | 1 |
| Ambrosius, WT; Batiuk, TD; Gassensmith, CM; Harezlak, J; Moe, SM; Murphy, CL; Russell, RR; Zekonis, M | 1 |
1 trial(s) available for thymidine and paricalcitol
| Article | Year |
|---|---|
A placebo-controlled trial to evaluate immunomodulatory effects of paricalcitol.
Topics: Adult; B-Lymphocytes; Calcitriol; Calcium; Double-Blind Method; Ergocalciferols; Female; Humans; Immunocompromised Host; Injections, Intravenous; Kidney Failure, Chronic; Leukocytes, Mononuclear; Male; Middle Aged; Parathyroid Hormone; Renal Dialysis; Thymidine | 2001 |
2 other study(ies) available for thymidine and paricalcitol
| Article | Year |
|---|---|
Effects of some drugs on human erythrocyte glucose 6-phosphate dehydrogenase: an in vitro study.
Topics: Adult; Binding, Competitive; Enzyme Inhibitors; Erythrocytes; Glucosephosphate Dehydrogenase; Humans; Kinetics; Male; Pentose Phosphate Pathway; Sulfur Compounds | 2010 |
The in vitro evaluation of 25-hydroxyvitamin D3 and 19-nor-1alpha,25-dihydroxyvitamin D2 as therapeutic agents for prostate cancer.
Topics: Calcifediol; Cell Count; Cell Division; Chloramphenicol O-Acetyltransferase; Dose-Response Relationship, Drug; Ergocalciferols; Humans; Male; Prostatic Neoplasms; Receptors, Calcitriol; Recombinant Fusion Proteins; Thymidine; Transcriptional Activation; Tritium; Tumor Cells, Cultured | 2000 |